Evidence map›Paper›PMID 25956922›Full record

ArticleCirculation. Cardiovascular imaging2015

Dynamic phenotypes of degenerative myxomatous mitral valve disease: quantitative 3-dimensional echocardiographic study.

Marie-Annick Clavel, Francesca Mantovani, Joseph Malouf, Hector I Michelena, Ori Vatury, Mothilal Sonia Jain, Sunil V Mankad, Rakesh M Suri, Maurice Enriquez-Sarano

Abstract read
PubMed Publisher
In one paragraph

Article in Circulation. Cardiovascular imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Sex-Based Differences in Mitral Annular Disjunction Severity and Arrhythmic Risk in Mitral Valve Prolapse.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Mitral Valve Prolapse-The Role of Cardiac Imaging Modalities.Structural heart : the journal of the Heart Team · 2022
    Review
  14. Malignant Mitral Valve Prolapse: Risk and Prevention of Sudden Cardiac Death.Current treatment options in cardiovascular medicine · 2022
    Article
  15. Mitral prolapsing volume is associated with increased cardiac dimensions in patients with mitral annular disjunction.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Marie-Annick ClavelFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Francesca MantovaniFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Joseph MaloufFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Hector I MichelenaFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Ori VaturyFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Mothilal Sonia JainFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Sunil V MankadFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Rakesh M SuriFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
Maurice Enriquez-SaranoFrom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN. sarano.maurice@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibro-elastic deficiency (FED) and diffuse myxomatous degeneration (DMD) are phenotypes of degenerative mitral valve disease defined morphologically. Whether physiological differences in annular and valvular dynamics exist between these phenotypes remains unknown. METHODS AND

resultsWe performed triple quantitation of cardiac remodeling and of mitral regurgitation severity and of annular and valvular dimensions by real-time 3-dimensional-transesophageal-echocardiography. Forty-nine patients with degenerative mitral valve disease classified as FED (n=31) and DMD (n=18) by surgical observation showed no difference in age (65±10 versus 59±13; P=0.5), body surface area (2.0±0.2 versus 2.0±0.2 m(2); P=0.5), left ventricular and atrial dimensions (all P>0.55), and mitral regurgitation regurgitant orifice (P=0.62). On average, annular dimensions were larger in DMD versus FED, but height was similar resulting in lower saddle shape. Dynamically, annular DMD versus FED display poorer contraction and saddle-shape accentuation in early systole and abnormal enlargement, particularly intercommissural, in late-systole (all P<0.05). Valvular dynamics showed stable valvular area in systole in FED versus considerable systolic increased area in DMD (P<0.001). Prolapse height and volume increased little throughout systole in FED versus marked increase in DMD (P<0.001).

conclusionsOur novel observations show that FED and DMD, although both labeled myxomatous, display considerable physiological phenotypic differences. In DMD, the annular increased size and profoundly abnormal dynamics demonstrate DMD-specific annular degeneration compared with the enlarged but relatively normal FED annulus. DMD does not incur more severe mitral regurgitation, despite larger prolapse and valve redundancy, underscoring potential compensatory role of tissue redundancy of DMD (or aggravating role of tissue paucity of FED) on mitral regurgitation severity.

Indexed as

AgedEchocardiography, Three-DimensionalEchocardiography, TransesophagealFemaleHumansIntraoperative PeriodMaleMiddle AgedMitral Valve InsufficiencyPhenotypeProspective StudiesSeverity of Illness Indexechocardiography, three-dimensionalheart valve diseasesmitral valve insufficiency

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.